New‐generation anticancer drugs and medication‐related osteonecrosis of the jaw (MRONJ): Late onset 3 years after ipilimumab endovenous administration with a possible role of target therapy

Wiley Open Access, Clinical Case Reports, 1(9), p. 61-66, 2020

Journal article published in 2020 by Agostino Guida

, Franco Ionna, Paolo A. Ascierto, Antonio M. Grimaldi

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving allowed

Upload

Published version: archiving allowed

Upload

Policy details

Data provided by